Additionally, it suppresses glandular secretion via vasoactive intestinal peptide-mediated sympathetic and parasympathetic inhibition.[5,6] Kikuchi et al[7] reported that local injections of BoNT-A in patients with spinal cerebellar ataxia type 1 and cervical dystonia resulted in alleviation of ataxia. The gene discussed is VIP; the disease is Ataxia.